Drug
Elx Tez Iva
Elx Tez Iva: highest development phase Phase 3, developed by Vertex Pharmaceuticals. 6 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Vertex Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| ELX/TEZ/IVA NCT04183790 | Phase 3 | Cystic Fibrosis |
| ELX/TEZ/IVA NCT04043806 | Phase 3 | Cystic Fibrosis |
| ELX/TEZ/IVA NCT05331183 | Phase 3 | Cystic Fibrosis |
| ELX/TEZ/IVA NCT05882357 | Phase 3 | Cystic Fibrosis |
| ELX/TEZ/IVA NCT04105972 | Phase 3 | Cystic Fibrosis |
| ELX/TEZ/IVA NCT04362761 | Phase 3 | Cystic Fibrosis |
Latest
No recent events.
Follow Elx Tez Iva on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.